Back
Surgery Partners Stock Price Chart
Sponsored
SGRY
Sponsored
Try a Free Stock Analysis With Definitive Buy Sell Hold Ratings
Analyze Any Stock Free
Sell
40
SGRY
Surgery Partners
Last Price:
$19.86
Seasonality Move:
5.45%
7 Day Trial
ALL ACCESS PASS
$
7
Free Stock Analysis Report: Get a clear concise Stock Rating
Analyze Any Stock Free-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SGRY is experiencing buying pressure, which is a positive indicator for future bullish movement.
Surgery Partners Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 20.97 | Buy |
20-day SMA: | 20.83 | Buy |
50-day SMA: | 23.43 | Sell |
200-day SMA: | 26.94 | Sell |
8-day EMA: | 20.94 | Buy |
20-day EMA: | 21.25 | Sell |
50-day EMA: | 23.25 | Sell |
200-day EMA: | 27.08 | Sell |
Surgery Partners Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.63 | Sell |
Relative Strength Index (14 RSI): | 46.18 | Sell |
Chaikin Money Flow: | 1158296 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.41 - 21.57) | Buy |
Bollinger Bands (100): | (22.66 - 31.94) | Sell |
Surgery Partners Technical Analysis
Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Surgery Partners Stock
Is Surgery Partners Stock a Buy?
-
Surgery Partners share price is 21.16 while SGRY 8-day simple moving average is 20.97, which is a Buy signal.
-
The stock price of SGRY is 21.16 while Surgery Partners 20-day SMA is 20.83, which makes it a Buy.
-
Surgery Partners 50-day simple moving average is 23.43 while SGRY share price is 21.16, making it a Sell technically.
-
SGRY stock price is 21.16 and Surgery Partners 200-day simple moving average is 26.94, creating a Sell signal.
SGRY Technical Analysis vs Fundamental Analysis
Sell
40
Surgery Partners (SGRY)
is a Sell
Is Surgery Partners a Buy or a Sell?
-
Surgery Partners stock is rated a SellThe current Surgery Partners [SGRY] share price is $21.16. The Score for SGRY is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
Surgery Partners Stock Info
Market Cap:
2.7B
Price in USD:
21.16
Share Volume:
1.3M
Surgery Partners 52-Week Range
52-Week High:
35.30
52-Week Low:
19.50
Sell
40
Surgery Partners (SGRY)
is a Sell
Surgery Partners Share Price Forecast
-
What is the Surgery Partners stock price today?The Surgery Partners stock price is 21.16 USD today.
-
Will SGRY stock go up or go down?Surgery Partners> share price is forecast to RISE/FALL based on technical indicators
-
Is Surgery Partners overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Surgery Partners is overvalued.
Is Surgery Partners Stock a Buy?
-
Surgery Partners share price is 21.16 while SGRY 8-day exponential moving average is 20.94, which is a Buy signal.
-
The stock price of SGRY is 21.16 while Surgery Partners 20-day EMA is 21.25, which makes it a Sell.
-
Surgery Partners 50-day exponential moving average is 23.25 while SGRY share price is 21.16, making it a Sell technically.
-
SGRY stock price is 21.16 and Surgery Partners 200-day simple moving average is 27.08, creating a Sell signal.
Fundamental Analysis of Surgery Partners
Is Surgery Partners a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.12 per share, and an increase next year of $0.27 per share.
Technical Analysis of Surgery Partners
Should I short Surgery Partners stock?
-
SGRY Moving Average Covergence Divergence (MACD) indicator is -0.63, suggesting Surgery Partners is a Sell
-
Surgery Partners Relative Strength Index (RSI) is 46.18, which suggest Surgery Partners is oversold
-
The Bollinger Bands (25) for Surgery Partners is (20.41 - 21.57), which suggest Surgery Partners is a Sell
-
The Bollinger Bands (100) for Surgery Partners is (22.66 - 31.94), which suggest Surgery Partners is a Sell
* Surgery Partners stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.